about
Lysergic acid diethylamide: a drug of 'use'?Constituents of Saffron (Crocus sativus L.) as Potential Candidates for the Treatment of Anxiety Disorders and SchizophreniaRevisiting the Basic Symptom Concept: Toward Translating Risk Symptoms for Psychosis into Neurobiological TargetsA Role for Estrogen in Schizophrenia: Clinical and Preclinical Findingsd-Lysergic Acid Diethylamide (LSD) as a Model of Psychosis: Mechanism of Action and Pharmacology.Converging models of schizophrenia--Network alterations of prefrontal cortex underlying cognitive impairments.Modulating NMDA Receptor Function with D-Amino Acid Oxidase Inhibitors: Understanding Functional Activity in PCP-Treated Mouse Model.Methodological issues associated with preclinical drug development and increased placebo effects in schizophrenia clinical trials.The current state of research on ayahuasca: A systematic review of human studies assessing psychiatric symptoms, neuropsychological functioning, and neuroimaging.Experimental Medicine in Psychiatry New Approaches in Schizophrenia, Depression and Cognition.How gender affects the pharmacotherapeutic approach to treating psychosis - a systematic review.Kynurenine and Tryptophan Levels in Patients With Schizophrenia and Elevated Antigliadin Immunoglobulin G Antibodies.Effects of aripiprazole on caffeine-induced hyperlocomotion and neural activation in the striatum.Purinergic system in psychiatric diseases.Ketamine-induced behavioural and brain oxidative changes in mice: an assessment of possible beneficial effects of zinc as mono- or adjunct therapy.Comparative effects of sertraline, haloperidol or olanzapine treatments on ketamine-induced changes in mouse behaviours.Positive allosteric modulation of M1 and M4 muscarinic receptors as potential therapeutic treatments for schizophrenia.Acute LSD effects on response inhibition neural networks.Effects of ketamine on brain function during smooth pursuit eye movements.
P2860
Q26746133-06581064-0C03-4996-AAA0-08EDBED931BEQ26767403-8039A3A7-D35D-46C6-9679-113DDFACF609Q26767499-804A2196-0516-4664-9F82-D49489F53952Q26778420-75EFEFAB-46D0-4F20-9B26-2CCDFB6D3AECQ28067851-2284FFBF-929A-4B18-A239-EFAA7A247634Q36307544-B25618E9-5996-4D76-B29B-B238DF211E92Q36642660-EF351B4C-AAF0-4858-8B55-5715EB0942B1Q38676860-2299C0C0-62D2-4B0A-841A-CC83B1994F3BQ38861685-C4A00C75-1054-4C4A-AA83-AF14725AF7C8Q38897362-146F400C-A48C-4989-8890-B95AAC5C4F7AQ38994958-73BDD0A0-63A0-4D45-B0E1-C709E29E9490Q41656861-9A5FB504-863E-4E2D-AB6E-1D145791B6D1Q42481687-275ADAB8-D0B5-49D2-B4FC-4464EF365E4AQ47758170-8CFBF1A0-D2C2-45FD-AECF-E4FB68B55833Q47824089-D7D9349D-8793-4407-AAE4-40A04C537569Q47869087-1D084193-9367-41A6-85A9-8E9ECAEB0981Q48001582-3BFE2842-E365-44A0-9948-0E3AB01909D3Q48088754-3CADA41E-94A1-485D-80C2-4EC13EFD1CD3Q48656998-68263B24-8E68-4CB2-99AE-1A45D2018C2C
P2860
description
2015 nî lūn-bûn
@nan
2015 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
2015 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
name
Drug models of schizophrenia
@ast
Drug models of schizophrenia
@en
Drug models of schizophrenia
@nl
type
label
Drug models of schizophrenia
@ast
Drug models of schizophrenia
@en
Drug models of schizophrenia
@nl
prefLabel
Drug models of schizophrenia
@ast
Drug models of schizophrenia
@en
Drug models of schizophrenia
@nl
P2860
P356
P1476
Drug models of schizophrenia
@en
P2093
Hannah Steeds
Robin L Carhart-Harris
P2860
P356
10.1177/2045125314557797
P407
P50
P577
2015-02-01T00:00:00Z